Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A22605 | 24418844 | Int J Obes (Lond) | Reduced hepatic aquaporin-9 and glycerol permeability are related to insulin resistance in non-alcoholic fatty liver disease. | 2013 | Details |
| A22607 | 24417951 | Best Pract Res Clin Endocrinol Metab | Adiponectin as a routine clinical biomarker. | 2013 | Details |
| A22608 | 24417949 | Best Pract Res Clin Endocrinol Metab | Adiponectin and the cardiometabolic syndrome: an epidemiological perspective. | 2013 | Details |
| A22609 | 24417250 | Aliment Pharmacol Ther | PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome. | 2014 | Details |
| A22610 | 24417071 | Klin Med (Mosk) | [Obesity and diseases of digestive organs]. | 2013 | Details |
| A22611 | 24415789 | J Infect Dis | Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels. | 2014 | Details |
| A22612 | 24415281 | Obes Surg | Nonalcoholic fatty liver disease in morbidly obese subjects: correlation among histopathologic findings, biochemical features, and ultrasound evaluation. | 2014 | Details |
| A22613 | 24412930 | Eur J Endocrinol | Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease. | 2014 | Details |
| A22614 | 24412604 | J Hepatol | MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury. | 2014 | Details |
| A22615 | 24411941 | Cell Metab | Regulation of steatohepatitis and PPARγ signaling by distinct AP-1 dimers. | 2014 | Details |
| A22616 | 24409043 | World J Gastroenterol | Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances. | 2013 | Details |
| A22617 | 24407920 | Diabetologia | The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial. | 2014 | Details |
| A22618 | 24404139 | PLoS One | Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression. | 2014 | Details |
| A22619 | 24403518 | J Pharmacol Exp Ther | Experimental nonalcoholic steatohepatitis increases exposure to simvastatin hydroxy acid by decreasing hepatic organic anion transporting polypeptide expression. | 2014 | Details |
| A22620 | 24402912 | J Cell Biochem | HIF-1α expression as a protective strategy of HepG2 cells against fatty acid-induced toxicity. | 2014 | Details |
| A22622 | 24402518 | Genes Nutr | A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease. | 2014 | Details |
| A22623 | 24402126 | Int J Mol Sci | Meta-omic platforms to assist in the understanding of NAFLD gut microbiota alterations: tools and applications. | 2014 | Details |
| A22624 | 24402015 | Arq Bras Endocrinol Metabol | Exenatide improves type 2 diabetes concomitant with non-alcoholic fatty liver disease. | 2013 | Details |
| A22625 | 24401715 | Am J Clin Nutr | Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. | 2014 | Details |
| A22626 | 24401223 | Atherosclerosis | Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. | 2013 | Details |
| A22627 | 24400795 | Immunology | Probiotic antigens stimulate hepatic natural killer T cells. | 2014 | Details |
| A22628 | 24397589 | Lipids Health Dis | Differential patterns of insulin secretion and sensitivity in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease versus patients with type 2 diabetes mellitus alone. | 2014 | Details |
| A22630 | 24396693 | Endocrinol Metab (Seoul) | Association of serum adipocyte-specific Fatty Acid binding protein with Fatty liver index as a predictive indicator of nonalcoholic Fatty liver disease. | 2013 | Details |
| A22631 | 24396649 | Endocrinol Metab (Seoul) | Tumor Necrosis Factor-α as a Predictor for the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Follow-Up Study. | 2013 | Details |
| A22632 | 24396406 | Exp Ther Med | Effects of glutamine on oxidative stress and nuclear factor-κB expression in the livers of rats with nonalcoholic fatty liver disease. | 2013 | Details |
| A22633 | 24395441 | J Cell Physiol | Protective effect of the Y220C mutant p53 against steatosis: good news? | 2014 | Details |
| A22634 | 24393106 | Antioxid Redox Signal | Mitochondrial dysfunction in obesity-associated nonalcoholic fatty liver disease: the protective effects of pomegranate with its active component punicalagin. | 2014 | Details |
| A22640 | 24390241 | Mol Biol Rep | Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease. | 2014 | Details |
| A22641 | 24389359 | J Mol Endocrinol | TRIB1 downregulates hepatic lipogenesis and glycogenesis via multiple molecular interactions. | 2014 | Details |
| A22642 | 24388885 | J Physiol Pharmacol | Apolipoprotein E4 allele is associated with substantial changes in the plasma lipids and hyaluronic acid content in patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A22643 | 24388027 | Mayo Clin Proc | Drug-induced liver injury. | 2014 | Details |
| A22644 | 24386588 | Case Rep Transplant | Single-lobe living donor liver transplant in a morbidly obese cirrhotic patient preceded by laparoscopic sleeve gastrectomy. | 2013 | Details |
| A22645 | 24385405 | Adv Ther | Effect of metformin on ballooning degeneration in nonalcoholic steatohepatitis (NASH): when to use metformin in nonalcoholic fatty liver disease (NAFLD). | 2014 | Details |
| A22647 | 24384368 | Semin Cell Dev Biol | Nuclear envelope-related lipodystrophies. | 2013 | Details |
| A22648 | 24382309 | Liver Int | Clinical and metabolic factors associated with development and regression of nonalcoholic fatty liver disease in nonobese subjects. | 2014 | Details |
| A22650 | 24381873 | Indian J Endocrinol Metab | Imaging of non alcoholic fatty liver disease: A road less travelled. | 2013 | Details |
| A22651 | 24381750 | J Nutr Metab | Cut-Off Values of Visceral Adiposity to Predict NAFLD in Brazilian Obese Adolescents. | 2013 | Details |
| A22652 | 24381427 | Indian J Clin Biochem | A Study of Carotid Atherosclerosis in Patients with Non-alcoholic Fatty Liver Disease. | 2012 | Details |
| A22653 | 24380887 | Biochem Pharmacol | Brain metabolic dysfunction at the core of Alzheimer's disease. | 2013 | Details |
| A22654 | 24379092 | Orv Hetil | [The role of fetuin-A in cardiovascular diseases]. | 2014 | Details |
| A22655 | 24379011 | Nutrients | Non-alcoholic steatohepatitis and hepatocellular carcinoma: implications for lycopene intervention. | 2013 | Details |
| A22656 | 24378747 | Curr Opin Lipidol | Cholesterol precursors: more than mere markers of biosynthesis. | 2014 | Details |
| A22657 | 24378529 | J Hepatol | Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations. | 2013 | Details |
| A22658 | 24378273 | Ann Hepatol | Effects of bile acid sequestration on hepatic steatosis in obese mice. | 2014 | Details |
| A22659 | 24378270 | Ann Hepatol | Statin use is not associated with liver related mortality. | 2014 | Details |
| A22660 | 24378267 | Ann Hepatol | Predictors of chronic liver disease in individuals with human immunodeficiency virus infection. | 2014 | Details |
| A22661 | 24377455 | Nutrition | Effects of bayberry juice on inflammatory and apoptotic markers in young adults with features of non-alcoholic fatty liver disease. | 2014 | Details |
| A22662 | 24377452 | Nutrition | Central obesity and altered peripheral adipose tissue gene expression characterize the NAFLD patient with insulin resistance: Role of nutrition and insulin challenge. | 2014 | Details |
| A22663 | 24377153 | Trop Gastroenterol | Patients with non-alcoholic fatty liver disease (NAFLD) have an increased risk of atherosclerosis and cardiovascular disease. | 2014 | Details |
| A22664 | 24376752 | PLoS One | COH-SR4 reduces body weight, improves glycemic control and prevents hepatic steatosis in high fat diet-induced obese mice. | 2013 | Details |
| A22665 | 24375711 | Hepatology | Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. | 2014 | Details |
| A22666 | 24375485 | Hepatology | Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2013 | Details |
| A22667 | 24375162 | Iran Biomed J | Prevention of nonalcoholic steatohepatitis in rats by two manganese-salen complexes. | 2014 | Details |
| A22668 | 24374462 | Cochrane Database Syst Rev | Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. | 2013 | Details |
| A22669 | 24374295 | J Hepatol | Altered profile of human gut microbiome is associated with cirrhosis and its complications. | 2013 | Details |
| A22670 | 24373781 | J Am Acad Dermatol | Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study. | 2013 | Details |
| A22671 | 24373555 | Nutr J | Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial. | 2013 | Details |
| A22672 | 24373179 | Diabetes Obes Metab | APOE*3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome. | 2014 | Details |
| A22673 | 24372862 | Hepatol Res | Upper limit of normal serum alanine aminotransferase levels in Japanese subjects. | 2014 | Details |
| A22674 | 24372861 | J Gastroenterol Hepatol | Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis. | 2014 | Details |
| A22675 | 24322028 | Rom J Morphol Embryol | Effect of diet and omega-3 fatty acids in NAFLD. | 2013 | Details |
| A22676 | 27508182 | J Hepatocell Carcinoma | Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma. | 2014 | Details |
| A22677 | 27335843 | ISRN Hepatol | The Wide and Complex Field of NAFLD Biomarker Research: Trends. | 2014 | Details |
| A22678 | 26528002 | Clujul Med | From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome? | 2014 | Details |
| A22679 | 26417275 | EXCLI J | Non-alcoholic fatty liver disease, diet and gut microbiota. | 2014 | Details |
| A22680 | 26237264 | J Clin Med | The Impacts of Obesity and Metabolic Abnormality on Carotid Intima-Media Thickness and Non-Alcoholic Fatty Liver Disease in Children from an Inland Chinese City. | 2014 | Details |
| A22681 | 26202413 | Hepatol Int | Non-alcoholic fatty liver disease in a young multiracial Asian population: a worrying ethnic predilection in Malay and Indian males. | 2014 | Details |
| A22682 | 26177557 | Cell Mol Biol (Noisy-le-grand) | Is C771G polymorphism of MLX interacting protein-like (MLXIPL) gene a novel genetic risk factor for non-alcoholic fatty liver disease? | 2014 | Details |
| A22683 | 26058106 | Eksp Klin Gastroenterol | [New metabolic index in the diagnosis of insulin resistance in patients with nonalcoholic fatty liver disease]. | 2014 | Details |
| A22684 | 26015978 | Mol Ther Methods Clin Dev | AAV8-mediated Sirt1 gene transfer to the liver prevents high carbohydrate diet-induced nonalcoholic fatty liver disease. | 2014 | Details |
| A22685 | 25960770 | Diabetol Metab Syndr | A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with Non-alcoholic fatty liver disease. | 2014 | Details |
| A22686 | 25951695 | Przegl Lek | [Determinants of nonalcoholic fatty liver disease in men and women with type 2 diabetes]. | 2014 | Details |
| A22687 | 25937854 | EPMA J | 4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics. | 2014 | Details |
| A22688 | 25911912 | Eksp Klin Gastroenterol | [Characteristics of the gastrointestinal myoelectrical activity in patients with nonalcoholic fatty liver disease associated with metabolic syndrome]. | 2014 | Details |
| A22689 | 25911911 | Eksp Klin Gastroenterol | [Hepatic parenchimatous damage and perfusion disturbance in the progression of nonalcoholic fatty liver disease]. | 2014 | Details |
| A22690 | 25911909 | Eksp Klin Gastroenterol | [Role of leptin and leptin resistance in non-alcoholic fatty liver disease development in persons with obesity and overweight]. | 2014 | Details |
| A22691 | 25911908 | Eksp Klin Gastroenterol | [Adipokines and liver function in patients with nonalcoholic fatty liver disease, type 2 diabetes mellitus and its combination]. | 2014 | Details |
| A22692 | 25859286 | Clin Epigenetics | Leucine alters hepatic glucose/lipid homeostasis via the myostatin-AMP-activated protein kinase pathway - potential implications for nonalcoholic fatty liver disease. | 2014 | Details |
| A22693 | 25842663 | Eksp Klin Gastroenterol | [Prevalence of nonalcoholic fatty liver disease in young patients with abdominal obesity and hypertension]. | 2014 | Details |
| A22694 | 25816629 | Vopr Pitan | [An analysis of the efficacy of low-calorie and isocaloric diets in obese patients with nonalcoholic steatohepatitis]. | 2014 | Details |
| A22695 | 25816621 | Vopr Pitan | [Isomeric specific analysis of hydroxyeicosatetraenoic acid in blood samples from obese patients with non-alcoholic and alcoholic steatohepatitis]. | 2014 | Details |
| A22696 | 25798442 | Front Med (Lausanne) | Knowing What's Out There: Awareness of Non-Alcoholic Fatty Liver Disease. | 2014 | Details |
| A22697 | 25796866 | Wiad Lek | [Variants of the course of non-alcoholic fatty liver disease in patients with ischemic heart disease and possibility of hypolipidemic therapy]. | 2014 | Details |
| A22698 | 25796862 | Wiad Lek | [The assessment of cardiovascular risk factors in patients with nonalcoholic fatty liver disease]. | 2014 | Details |
| A22699 | 25796845 | Wiad Lek | [The use of complex tools ezetimibe, hepadyfu fosinopril and correction of blood pressure and endothelial dysfunction in patients with nonalcoholic steatohepatitis and essential hypertension stage II]. | 2014 | Details |
| A22700 | 25796814 | Wiad Lek | Combined effect of appointment telmisartan and atorvastatin on hemodynamic indicators and the indicators of lipid profile in patients with arterial hypertension combined with obesity and steatohepatitis. | 2014 | Details |
| A22701 | 25790713 | Klin Med (Mosk) | [Association of leptin and total immunoglobulin E in obese patients]. | 2014 | Details |
| A22702 | 25763333 | Anal Cell Pathol (Amst) | Nonalcoholic fatty liver disease: different classifications concordance and relationship between degrees of morphological features and spectrum of the disease. | 2014 | Details |
| A22703 | 25744638 | Nihon Rinsho Meneki Gakkai Kaishi | [Cellular senescence and chronic inflammation]. | 2014 | Details |
| A22705 | 24368431 | J Nutr | Choline supplementation protects against liver damage by normalizing cholesterol metabolism in Pemt/Ldlr knockout mice fed a high-fat diet. | 2013 | Details |
| A22706 | 24367597 | PLoS One | Therapy of experimental NASH and fibrosis with galectin inhibitors. | 2013 | Details |
| A22707 | 24366230 | Curr Opin Lipidol | Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field. | 2014 | Details |
| A22708 | 24365744 | Transl Res | Coffee enhances the expression of chaperones and antioxidant proteins in rats with nonalcoholic fatty liver disease. | 2013 | Details |
| A22709 | 24365733 | Korean J Gastroenterol | Common carotid intima-media thickness in patients with non-alcoholic fatty liver disease: a population-based case-control study. | 2013 | Details |
| A22710 | 24365277 | Med Hypotheses | Nonalcoholic fatty liver disease (NAFLD): a new risk factor for adverse cardiovascular events in dialysis patients. | 2013 | Details |
| A22711 | 24364104 | Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi | [Changes of serum aminotransferase in children with obstructive sleep apnea hypopnea syndrome]. | 2013 | Details |
| A22712 | 24363521 | World J Gastroenterol | Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders. | 2013 | Details |
| A22713 | 24363514 | World J Gastroenterol | Cross-talk between the thyroid and liver: a new target for nonalcoholic fatty liver disease treatment. | 2013 | Details |
| A22714 | 24362075 | J Hepatol | Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation. | 2013 | Details |
| A22715 | 24361606 | Biochim Biophys Acta | Lipoic acid prevents fructose-induced changes in liver carbohydrate metabolism: role of oxidative stress. | 2013 | Details |